Integration, transversality, multidisciplinarity - the Lille Inflammation Research International Center (LIRIC) is the only one of its kind in the world. It conducts an international-level scientific and medical research to understand and to treat inflammatory diseases. LIRIC brings together some 140 researchers organized in open, cross-disciplinary teams to study inflammatory conditions, with the objective of providing new specific treatment solutions for patients.
Fields of expertise
- Medicinal Chemistry and Drug Design
- Molecular modeling
- Clinical observation and follow-up
- Pathophysiology of epithelia
At the heart of one of the largest European hospital complexes
LIRIC brings together many complementary teams around common scientific goals - a key asset to address the complexity of inflammatory diseases and an innovation accelerator for patient care. The LIRIC teams are based at the heart of Lille University Hospital (CHU), one of Europe’s largest hospital complexes, thus getting direct access to clinicians, technology platforms and clinical research centers.
2001 – 2010
Strong expertise in chronic Inflammatory Bowel Diseases
Founded in 2001, the U995 laboratory was first established as an excellence research laboratory in the field of chronic Inflammatory Bowel Disease (IBD). The laboratory teams, gathering 25 researchers in 2010, became experts in the understanding of the pathophysiological phenomena and in the identification of new therapeutic targets.
2010 – 2015
Research extension to other types of inflammation
Over five years, the U995 laboratory increased its scientific activities threefold and extended its expertise to other inflammatory conditions, thus becoming a reference scientific center in the area of inflammation.
2015 – Today
The birth of an international research center
The LIRIC-UMR 995 now consists of 140 researchers divided into 7 specialized teams with a common objective: to understand and treat inflammatory diseases.